CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.

21:33 26/01/2026

China Resources Pharmaceutical (03320) announced that its non-wholly-owned subsidiary, China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane), has received a registration approval notice (CSRC License [2026] No. 118) from the China Securities Regulatory Commission for its proposed issuance of corporate bonds to qualified investors in the People's Republic of China (China). The notice is valid for 24 months from the date of issuance, during which China Resources Double-Crane can issue corporate bonds with a total amount of 3 billion yuan in installments.

CHINARES PHARMA (03320) announces that its non-wholly owned subsidiary China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane Pharmaceutical) has received a registration approval notice (CSRC License [2026] No. 118) from the China Securities Regulatory Commission for the proposed issuance of corporate bonds by China Resources Double-Crane Pharmaceutical to qualified investors in the People's Republic of China. The notice is valid for 24 months from the date of issuance, during which China Resources Double-Crane Pharmaceutical may issue corporate bonds in installments totaling RMB 3 billion.

FULLSHARE (00607) intends to discount approximately 20% to issue 127 million subscribed shares, raising a net of approximately HK$1.32 billion.

HOMELAND ITL(03798) subscription and redemption of wealth management products

GR LIFE STYLE (00108) signs a strategic cooperation memorandum with Mingzhi Medical to jointly promote the in-depth integration and industrial upgrading of "medical + technology + scenarios".

FULLSHARE (00607) intends to discount approximately 20% to issue 127 million subscribed shares, raising a net of approximately HK$1.32 billion.

HOMELAND ITL(03798) subscription and redemption of wealth management products

GR LIFE STYLE (00108) signs a strategic cooperation memorandum with Mingzhi Medical to jointly promote the in-depth integration and industrial upgrading of "medical + technology + scenarios".